pillbase.ru

Parsabiv

Active substance: etelcalcetide

etelcalcetide hydrochloride

Centralised EU authorisationActive

Marketing holder: Amgen Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • PARSABIV
    INJECTION, SOLUTION · ETELCALCETIDE HYDROCHLORIDE 2.5 mg/.5mL
    55513-740
    Amgen, Inc
  • PARSABIV
    INJECTION, SOLUTION · ETELCALCETIDE HYDROCHLORIDE 5 mg/mL
    55513-741
    Amgen, Inc
  • PARSABIV
    INJECTION, SOLUTION · ETELCALCETIDE HYDROCHLORIDE 10 mg/2mL
    55513-742
    Amgen, Inc
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-783d-7170-87d6-e09e598576d3,01a1208d-455c-7d70-a779-3139949ded0d,01a1208d-4560-7411-b98c-2357a5feb50b;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003995
Registration status
Active
ATC code
H05BX04
Sources
  • product · EMA · EMEA/H/C/003995 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003995 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003995 · Verified 2026-10-09